tiprankstipranks
Raffles Medical Group Ltd (RAFLF)
OTHER OTC:RAFLF
US Market
RAFLF
Raffles Medical Group
RESEARCH TOOLSreports

Raffles Medical Group (RAFLF) Ratios

20 Followers

Raffles Medical Group Ratios

RAFLF's free cash flow for Q2 2026 was S$0.44. For the 2026 fiscal year, RAFLF's free cash flow was decreased by S$ and operating cash flow was S$0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.30 1.31 1.35 1.28 1.36
Quick Ratio
 1.26 1.27 1.32 1.24 1.33
Cash Ratio
 0.86 0.93 0.90 0.91 0.70
Solvency Ratio
 0.29 0.30 0.22 0.24 0.39
Operating Cash Flow Ratio
 0.36 0.32 0.23 0.50 0.54
Short-Term Operating Cash Flow Coverage
 0.00 2.13 12.56 10.67 20.30
Net Current Asset Value
S$ 53.09MS$ 61.83MS$ 50.51MS$ 319.00KS$ 27.05M
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.06 0.06 0.08 0.06
Debt-to-Equity Ratio
 0.03 0.08 0.08 0.12 0.09
Debt-to-Capital Ratio
 0.03 0.08 0.08 0.11 0.09
Long-Term Debt-to-Capital Ratio
 0.00 0.03 0.04 0.06 0.06
Financial Leverage Ratio
 1.33 1.35 1.46 1.49 1.48
Debt Service Coverage Ratio
 0.00 2.03 8.60 4.39 11.35
Interest Coverage Ratio
 0.00 21.31 14.27 19.04 28.46
Debt to Market Cap
 0.00 0.04 0.04 0.04 0.03
Interest Debt Per Share
 0.02 0.05 0.05 0.07 0.06
Net Debt to EBITDA
 -2.01 -1.71 -1.92 -1.65 -0.67
Profitability Margins
Gross Profit Margin
44.35%17.87%64.68%44.62%77.77%
EBIT Margin
11.14%11.40%12.18%15.28%23.91%
EBITDA Margin
15.35%17.07%17.75%18.77%28.66%
Operating Profit Margin
11.73%11.40%10.98%16.35%23.80%
Pretax Profit Margin
12.00%12.10%11.57%16.87%23.30%
Net Profit Margin
9.12%9.22%8.28%12.73%17.40%
Continuous Operations Profit Margin
9.17%9.29%8.29%12.87%17.43%
Net Income Per EBT
75.96%76.19%71.57%75.48%74.71%
EBT Per EBIT
102.26%106.14%105.42%103.18%97.89%
Return on Assets (ROA)
4.88%4.94%4.07%5.90%9.56%
Return on Equity (ROE)
6.42%6.67%5.93%8.77%14.11%
Return on Capital Employed (ROCE)
8.06%7.96%7.18%10.08%17.26%
Return on Invested Capital (ROIC)
6.10%5.79%5.07%7.50%12.36%
Return on Tangible Assets
4.93%4.98%4.11%5.97%9.69%
Earnings Yield
4.36%3.74%3.94%4.45%5.51%
Efficiency Ratios
Receivables Turnover
 6.05 6.73 4.64 12.72 3.61
Payables Turnover
 2.45 3.40 1.21 1.86 0.80
Inventory Turnover
 38.57 55.81 24.66 31.46 9.66
Fixed Asset Turnover
 1.01 1.03 1.00 0.92 1.11
Asset Turnover
 0.54 0.54 0.49 0.46 0.55
Working Capital Turnover Ratio
 8.21 6.47 6.27 5.98 10.70
Cash Conversion Cycle
 -79.03 -46.42 -207.03 -155.84 -314.51
Days of Sales Outstanding
 60.38 54.25 78.62 28.69 101.18
Days of Inventory Outstanding
 9.46 6.54 14.80 11.60 37.78
Days of Payables Outstanding
 148.87 107.21 300.45 196.12 453.47
Operating Cycle
 69.84 60.79 93.42 40.29 138.96
Cash Flow Ratios
Operating Cash Flow Per Share
 0.06 0.06 0.05 0.10 0.11
Free Cash Flow Per Share
 0.05 0.05 0.04 0.09 0.09
CapEx Per Share
 <0.01 <0.01 0.01 0.01 0.01
Free Cash Flow to Operating Cash Flow
 0.93 0.93 0.76 0.89 0.87
Dividend Paid and CapEx Coverage Ratio
 1.73 1.96 1.32 2.08 2.54
Capital Expenditure Coverage Ratio
 13.56 13.47 4.13 9.22 7.76
Operating Cash Flow Coverage Ratio
 3.20 1.21 0.98 1.52 2.04
Operating Cash Flow to Sales Ratio
 0.15 0.14 0.11 0.27 0.24
Free Cash Flow Yield
6.55%5.20%4.14%8.33%6.57%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 22.95 26.77 25.37 22.48 18.16
Price-to-Sales (P/S) Ratio
 2.09 2.47 2.10 2.86 3.16
Price-to-Book (P/B) Ratio
 1.49 1.78 1.50 1.97 2.56
Price-to-Free Cash Flow (P/FCF) Ratio
 15.27 19.23 24.16 12.01 15.21
Price-to-Operating Cash Flow Ratio
 14.17 17.81 18.30 10.71 13.25
Price-to-Earnings Growth (PEG) Ratio
 3.59 1.95 -0.82 -0.60 0.25
Price-to-Fair Value
 1.49 1.78 1.50 1.97 2.56
Enterprise Value Multiple
 11.60 12.73 9.92 13.60 10.36
Enterprise Value
 1.32B 1.66B 1.32B 1.81B 2.44B
EV to EBITDA
 11.60 12.73 9.92 13.60 10.36
EV to Sales
 1.78 2.17 1.76 2.55 2.97
EV to Free Cash Flow
 13.02 16.96 20.25 10.71 14.29
EV to Operating Cash Flow
 12.06 15.70 15.34 9.55 12.45
Tangible Book Value Per Share
 0.56 0.56 0.57 0.55 0.54
Shareholders’ Equity Per Share
 0.57 0.57 0.57 0.55 0.55
Tax and Other Ratios
Effective Tax Rate
 0.24 0.23 0.28 0.24 0.25
Revenue Per Share
 0.40 0.41 0.40 0.38 0.44
Net Income Per Share
 0.04 0.04 0.03 0.05 0.08
Tax Burden
 0.76 0.76 0.72 0.75 0.75
Interest Burden
 1.08 1.06 0.95 1.10 0.97
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.22 0.07 0.06 0.19 0.13
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 1.62 1.50 1.39 2.10 1.37
Currency in SGD